Axsome Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Axsome Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Axsome Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Axsome Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.5M | 44k | 79.59 |
| 2023-09-30 | $4.0M | 57k | 69.89 |
| 2023-06-30 | $4.4M | 61k | 71.86 |
| 2023-03-31 | $2.5M | 40k | 61.68 |
| 2022-12-31 | $3.5M | 45k | 77.13 |
| 2022-09-30 | $2.7M | 62k | 44.62 |
| 2022-06-30 | $1.4M | 36k | 38.31 |
| 2022-03-31 | $1.9M | 46k | 41.67 |
| 2021-12-31 | $4.7M | 122k | 38.04 |
| 2021-09-30 | $3.2M | 99k | 32.93 |
| 2021-06-30 | $2.4M | 35k | 68.00 |
| 2021-03-31 | $2.2M | 39k | 56.55 |
| 2020-12-31 | $3.0M | 36k | 81.48 |
| 2020-09-30 | $1.2M | 23k | 52.63 |
| 2020-06-30 | $2.2M | 27k | 82.29 |
| 2020-03-31 | $926k | 16k | 58.71 |
| 2019-12-31 | $4.2M | 41k | 103.37 |
| 2019-09-30 | $371k | 18k | 20.25 |
| 2019-06-30 | $572k | 22k | 25.69 |
| 2017-06-30 | $93k | 17k | 5.50 |